Havens Advisors’s Auspex Pharmaceuticals ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-15,000
Closed -$1.51M – 43
2015
Q1
$1.51M Buy
+15,000
New +$999K 1.21% 25

Havens Advisors's ASPX Position: Q2 2015 in Review

Havens Advisors sold out of Auspex Pharmaceuticals (ASPX) in Q2 2015, closing a stake of 15,000 shares — an estimated $1.51M sold.

Havens Advisors first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $1.51M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Havens Advisors reported no remaining Auspex Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Havens Advisors sold 15,000 Auspex Pharmaceuticals shares in Q2 2015, an estimated $1.51M.
  • Havens Advisors first reported a position in Auspex Pharmaceuticals in Q1 2015 and held it in 1 quarter.
  • Havens Advisors's Auspex Pharmaceuticals position peaked at $1.51M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Auspex Pharmaceuticals as of Q2 2015.

Based on Havens Advisors's 13F filing for Q2 2015, filed 6 Aug 2015.